BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17108211)

  • 21. A novel mutation in the DNASE1 gene is related with protein instability and decreased enzyme activity in thyroid autoimmunity.
    Dittmar M; Bischofs C; Matheis N; Poppe R; Kahaly GJ
    J Autoimmun; 2009 Feb; 32(1):7-13. PubMed ID: 19022625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of Pulmozyme (dornase alpha) stability using a kinetic colorimetric DNase I activity assay.
    Lichtinghagen R
    Eur J Pharm Biopharm; 2006 Jul; 63(3):365-8. PubMed ID: 16682175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and comparative study of cell-free nucleic acids from human urine.
    Bryzgunova OE; Skvortsova TE; Kolesnikova EV; Starikov AV; Rykova EY; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2006 Sep; 1075():334-40. PubMed ID: 17108229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homogeneous Immunochemical Assay on the Lateral Flow Strip for Measurement of DNase I Activity.
    Zhang Y; Ying JY
    Anal Chem; 2015 Oct; 87(20):10193-8. PubMed ID: 26417694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliable ferrocenyloligonucleotide-immobilized electrodes and their application to electrochemical DNase I assay.
    Sato S; Fujita K; Kanazawa M; Mukumoto K; Ohtsuka K; Takenaka S
    Anal Chim Acta; 2009 Jul; 645(1-2):30-5. PubMed ID: 19481627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incubation with DNase I inhibits tumor cell proliferation.
    Alcázar-Leyva S; Cerón E; Masso F; Montaño LF; Gorocica P; Alvarado-Vásquez N
    Med Sci Monit; 2009 Feb; 15(2):CR51-55. PubMed ID: 19179967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
    Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
    Cancer Lett; 2008 May; 263(2):170-81. PubMed ID: 18395974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
    Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
    Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects.
    Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G
    Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.
    Capizzi E; Gabusi E; Grigioni AD; De Iaco P; Rosati M; Zamagni C; Fiorentino M
    Diagn Mol Pathol; 2008 Mar; 17(1):34-8. PubMed ID: 18303408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrochemical assay for deoxyribonuclease I activity.
    Sato S; Fujita K; Kanazawa M; Mukumoto K; Ohtsuka K; Waki M; Takenaka S
    Anal Biochem; 2008 Oct; 381(2):233-9. PubMed ID: 18674511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of DNase activity in seminal plasma and uptake of exogenous DNA by spermatozoa of the Brazilian flounder Paralichthys orbignyanus.
    Lanes CF; Sampaio LA; Marins LF
    Theriogenology; 2009 Feb; 71(3):525-33. PubMed ID: 18849066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
    Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
    Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma.
    Dincer Y; Himmetoglu S; Akcay T; Ersoy EY; Gunes KN; Tortum O
    Neoplasma; 2007; 54(2):131-6. PubMed ID: 17319786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.